Screening for Breast Cancer
Authors: Saika Kumiko, Saito Hiroshi, Ohuchi Noriaki, Sobue Tomotaka
Journal: Annals of Internal Medicine (2010)

Letters2 November 2010Screening for Breast CancerSaika Kumiko, PhD, Saito Hiroshi, MD, PhD, Ohuchi Noriaki, MD, PhD, and Sobue Tomotaka, MD, PhD, MPHSaika Kumiko, PhDFrom National Cancer Center, Tokyo 104-0045, Japan.Search for more papers by this author, Saito Hiroshi, MD, PhDFrom National Cancer Center, Tokyo 104-0045, Japan.Search for more papers by this author, Ohuchi Noriaki, MD, PhDFrom National Cancer Center, Tokyo 104-0045, Japan.Search for more papers by this author, and Sobue Tomotaka, MD, PhD, MPHFrom National Cancer Center, Tokyo 104-0045, Japan.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-153-9-201011020-00016 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:In 2009, the U.S. Preventive Services Task Force (USPSTF) recommended that starting regular screening mammography before the age of 50 years should be an individual decision that takes patient context into account, including the patient's values regarding specific benefits and harms (1, 2). As a metric, Nelson and colleagues (3) calculated the number needed to invite (NNI) to screening to prevent 1 death from breast cancer by conducting a meta-analysis of several trials. They concluded that the net benefit is smaller for women aged 40 to 49 years with a larger NNI than for women aged 50 ...References1. US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:716-26, W-236. [PMID: 19920272] MedlineGoogle Scholar2. U.S. Preventive Services Task Force. Screening for breast cancer. November 2009. Accessed at www.uspreventiveservicestaskforce.org/uspstf/uspsbrca.htm on 7 September 2010. Google Scholar3. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L; U.S. Preventive Services Task Force. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:727-37. [PMID: 19920273] LinkGoogle Scholar4. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS—a Bayesian modeling framework: concepts, structure, and extensibility. Stat Comput. 2000;10:325-37. CrossrefGoogle Scholar5. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909-19. [PMID: 11918907] CrossrefMedlineGoogle Scholar6. Habbema JD, van Oortmarssen GJ, van Putten DJ, Lubbe JT, van der Maas PJ. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. J Natl Cancer Inst. 1986;77:317-20. [PMID: 3461193] MedlineGoogle Scholar7. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002;137:305-12. [PMID: 12204013] LinkGoogle Scholar8. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L; Trial Management Group. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 2006;368:2053-60. [PMID: 17161727] CrossrefMedlineGoogle Scholar9. Bjurstam N, Björneld L, Warwick J, Sala E, Duffy SW, Nyström L, et al. The Gothenburg Breast Screening Trial. Cancer. 2003;97:2387-96. [PMID: 12733136] CrossrefMedlineGoogle Scholar10. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer. 1995;75:2507-17. [PMID: 7736395] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From National Cancer Center, Tokyo 104-0045, Japan.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoThe Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years Anthony B. Miller , Teresa To , Cornelia J. Baines , and Claus Wall The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years Anthony B. Miller , Teresa To , Cornelia J. Baines , and Claus Wall Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation StatementScreening for Breast Cancer: An Update for the U.S. Preventive Services Task Force Heidi D. Nelson , Kari Tyne , Arpana Naik , Christina Bougatsos , Benjamin K. Chan , and Linda Humphrey Metrics Cited ByControversies in Breast Cancer Screening for Women Aged 40-49 YearsEfficacy of Sonazoid (Perflubutane) for Contrast-Enhanced Ultrasound in the Differentiation of Focal Breast Lesions: Phase 3 Multicenter Clinical TrialA Randomized Controlled Trial to Verify the Efficacy of the Use of Ultrasonography in Breast Cancer Screening Aged 40-49 (J-START): 76 196 Women RegisteredThe Number Needed to Invite（NNI）for Breast Cancer Mammography Screening in Japan 2 November 2010Volume 153, Issue 9Page: 618-619KeywordsAge groupsBiostatisticsBreast cancerCancer screeningConflicts of interestDeath ratesMammography ePublished: 2 November 2010 Issue Published: 2 November 2010 CopyrightCopyright © 2010 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...